Actively Recruiting
eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
Led by University of British Columbia · Updated on 2025-09-25
60
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
X
Xavier University of Louisiana.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.
CONDITIONS
Official Title
eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-report a current or history of gynecologic cancer of any subtype
- Self-report symptoms of sexual difficulties and score greater than 11 on the Female Sexual Distress Scale-Revised
- Be fluent in English to use the eSense content
- Have reliable internet access and basic skills to use online platforms
- Be available for 8 to 16 weeks to complete eSense modules and questionnaires
- Any gender
You will not qualify if you...
- Have visual impairments or disabilities that interfere with reading or interacting with online materials
- Have poorly managed anxiety or mood disorders causing significant life interference
- Be currently receiving active cancer treatment, including radiation, chemotherapy, or planned surgeries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of British Columbia
Vancouver, British Columbia, Canada, V5Z 1M9
Actively Recruiting
Research Team
N
Nisha Marshall, MSc
CONTACT
K
Kira McNamee
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here